Polyrizon Ltd.
PLRZ
$11.15
▼
-0.35
(-3.04%)
at close
5
Visible periods
5
Metrics
Peer-ranked
Benchmarks
Price Chart
43
Health
Weak
Neutral
auto_awesome
Analytical Summary
Polyrizon Ltd. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.
Market Cap
—
Dividend Yield
—
Revenue Growth
—
Op. Margin
—
ROIC
—
FCF / Share
—
Trailing P/E
—
Price / Book
0.9x
FCF Yield
—
Debt / Equity
—
info
Valuation on last close. End-of-day price, Aug 7, 2026.
Health Breakdown
Returns
30
Cash Quality ↓
77
Financial view
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
Is the balance sheet risky?
1 metrics
How resilient is the balance sheet?
2 metrics
⌨️ Keyboard Shortcuts
/ Search
Esc Clear
A Annual
Q Quarterly
1-7 Jump to category
R Reset
Secondary lens
Benchmark Lens
Compare PLRZ against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare PLRZ against peers after checking the statement evidence.
Percentile Rankings
How PLRZ compares to all companies
Return on Common Equity (%)
-15.9%
Bottom 50%
Peers: Top 44%
Peer Comparison
PLRZ vs similar peers
Return on Common Equity (%)
PLRZ
-15.9%
#43 of 97
IDXG
109.9%
MMM
69.1%
MDNC
50.6%
Peer median: -24.33
Profit Margin (%)
PLRZ
—
#None of 62
RMD
27.2%
IRMD
26.8%
LMAT
23.1%
Peer median: -2.65
Debt to Equity
PLRZ
—
#None of 57
TCMD
0.00x
UTMD
0.00x
ICCM
0.00x
Peer median: 0.45
Operating Margin (%)
PLRZ
—
#None of 62
RMD
32.7%
IRMD
31.2%
LMAT
27.2%
Peer median: -0.50
Compare PLRZ with peers
Stack PLRZ against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 5 years · 5 quarters